Manbro Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 1.50 M
as on 15-11-2024
- Company Age 31 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.69 Cr
as on 15-11-2024
- Satisfied Charges ₹ 3.59 Cr
as on 15-11-2024
- Revenue -17.45%
(FY 2023)
- Profit -4812.89%
(FY 2023)
- Ebitda -108.93%
(FY 2023)
- Net Worth -54.21%
(FY 2023)
- Total Assets -2.22%
(FY 2023)
About Manbro Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.69 Cr. The company has closed loans amounting to ₹3.59 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manjudevi Choudhary and Dineshkumar Choudhary serve as directors at the Company.
- CIN/LLPIN
U24233MH1993PTC075432
- Company No.
075432
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Manbro Pharma Private Limited offer?
Manbro Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Herbal Cough Syrup, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Brain Tonic, Ayurvedic Medicine, Herbal Memory Booster Capsules Tablets, Ayurvedic Health Tonic, Herbal Supplements, Herbal Slimming Capsule Tablet, Ayurvedic, Herbal Oils and Cosmetics.
Who are the key members and board of directors at Manbro Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manjudevi Choudhary  | Director | 10-Jan-2018 | Current |
| Dineshkumar Choudhary | Director | 09-Apr-2008 | Current |
Financial Performance of Manbro Pharma.
Manbro Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.45% decrease. The company also saw a substantial fall in profitability, with a 4812.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manbro Pharma?
In 2022, Manbro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jul 2021 | ₹2.20 Cr | Open |
Hdfc Bank Limited Creation Date: 05 Jun 2021 | ₹1.58 M | Open |
Dombivli Nagari Sahakari Bank Limited Creation Date: 27 Jan 2007 | ₹3.30 M | Open |
How Many Employees Work at Manbro Pharma?
Manbro Pharma has a workforce of 9 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manbro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manbro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
